Related references
Note: Only part of the references are listed.Modulation of the Endocannabinoid System Following Central Nervous System Injury
Juan Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Age and sex differences in the pathophysiology of acute CNS injury
TaeHee Kim et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Acute Ischemic Stroke: Management Approach
Chandril Chugh
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2019)
Partners in crime: neutrophils and monocytes/macrophages in inflammation and disease
Kathryn Prame Kumar et al.
CELL AND TISSUE RESEARCH (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Sex Differences in Neuroinflammation and Neuroprotection In Ischemic Stroke
Monica S. Spychala et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Neuroinflammation as Fuel for Axonal Regeneration in the Injured Vertebrate Central Nervous System
Ilse Bollaerts et al.
MEDIATORS OF INFLAMMATION (2017)
Infections Up to 76 Days After Stroke Increase Disability and Death
Annastazia E. Learoyd et al.
TRANSLATIONAL STROKE RESEARCH (2017)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome
Ian Burkovskiy et al.
MICROCIRCULATION (2016)
Evidence for an Age-Dependent Decline in Axon Regeneration in the Adult Mammalian Central Nervous System
Cedric G. Geoffroy et al.
CELL REPORTS (2016)
Immune interventions in stroke
Ying Fu et al.
NATURE REVIEWS NEUROLOGY (2015)
Targeting secondary injury in intracerebral haemorrhage-perihaematomal oedema
Sebastian Urday et al.
NATURE REVIEWS NEUROLOGY (2015)
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
Seong-Jin Yu et al.
PLOS ONE (2015)
Immunological consequences of ischemic stroke
A. Vogelgesang et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome
C. Lehmann et al.
MEDICAL HYPOTHESES (2014)
CB2 Cannabinoid Receptors as a Therapeutic Target-What Does the Future Hold?
Amey Dhopeshwarkar et al.
MOLECULAR PHARMACOLOGY (2014)
Influence of Peripheral inflammation on the progression of multiple sclerosis: Evidence from the clinic and experimental animal models
Veronica Murta et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2013)
Sex differences in cannabinoid pharmacology: A reflection of differences in the endocannabinoid system?
Rebecca M. Craft et al.
LIFE SCIENCES (2013)
Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
Servio H. Ramirez et al.
JOURNAL OF NEUROSCIENCE (2012)
Post-stroke infection: A systematic review and meta-analysis
Willeke F. Westendorp et al.
BMC NEUROLOGY (2011)
Immunological consequences of ischemic stroke: Immunosuppression and autoimmunity
Antje Vogelgesang et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
The immunology of stroke: from mechanisms to translation
Costantino Iadecola et al.
NATURE MEDICINE (2011)
The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic Implications
Lydia K. Miller et al.
PHARMACOLOGICAL REVIEWS (2011)
Brain dendritic cells in ischemic stroke: Time course, activation state, and origin
Jennifer C. Felger et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
Sadiye Amcaoglu Rieder et al.
IMMUNOBIOLOGY (2010)
Sex Differences in Outcome after Mild Traumatic Brain Injury
Jeffrey J. Bazarian et al.
JOURNAL OF NEUROTRAUMA (2010)
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Javier Palazuelos et al.
BRAIN (2009)
Neutrophil Adhesion and Activation under Flow
Alexander Zarbock et al.
MICROCIRCULATION (2009)
Infarct Volume is a Major Determiner of Post-Stroke Immune Cell Function and Susceptibility to Infection
Andreas Hug et al.
STROKE (2009)
Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model
Ming Zhang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Stroke-induced immunodepression - Experimental evidence and clinical relevance
Ulrich Dirnagl et al.
STROKE (2007)
Central nervous system injury-induced immune deficiency syndrome
C Meisel et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
K Maresz et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial
S Aslanyan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model
X Ni et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Focal lesions in the rat central nervous system induced by endothelin-1
PM Hughes et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation
K Prass et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A serial MR study of cerebral blood flow changes and lesion development following endothelin-1-induced ischemia in rats
J Biernaskie et al.
MAGNETIC RESONANCE IN MEDICINE (2001)
Share Paper
